Prescription Required
Gefifect 250mg Tablet 10s is generally used for cancer management. It operates by attacking the epidermal growth factor receptor (EGFR) existing in both healthy and malignant cells, disrupting crucial signaling pathways for the proliferation of cancer cells.
Gefitinib is grouped under cancer drugs and is deployed to address certain types of cancers by curbing cancer cell proliferation. It homes in on the epidermal growth factor receptor (EGFR), that exists in both normal and cancerous cells. By obstructing particular proteins associated with this receptor, Gefitinib impedes the signal channels crucial for cancer cell proliferation and survival. Essentially, it puts a halt to the rampant proliferation of cancerous cells.
Adhere to the prescribed quantity and duration as instructed by your general physician. This medication can be consumed with or without meals but it is beneficial to maintain a regular time each day for best results.
Typical side effects might include diarrhea, arid skin, decreased appetite, queasiness, skin rash, stomatitis (inflammation in mouth), sickness, fatigue, and weight reduction.
It has been linked with an elevated danger of interstitial lung disease, a grave condition. Patients ought to be monitored for symptoms such as persistent cough, labored breathing, and high temperature. Immediate medical care is required if these symptoms manifest, and medication may need to be paused or halted.
Should a dosage be missed, consume it when remembered. However, if the subsequent dose is imminent, bypass the forgotten one and proceed with the regular dosage schedule. Refrain from doubling up on doses. Seek advice from your physician for managing forgotten doses efficiently.
It is dangerous to use alcohol concurrently with Gefifect 250mg Tablet 10s due to the likelihood of adverse effects and increased risks.
During pregnancy, Gefifect 250mg Tablet 10s is considered unsafe, with definite proof of potential harm to the unborn child. Ask your doctor for alternatives in necessary circumstances.
Caution is advised when breastfeeding and taking Gefifect 250mg Tablet 10s. Limited data from humans indicates possible transmission via breast milk, creating a risk to the infant.
Gefifect 250mg Tablet 10s should be used with caution in severe kidney disease. Dose adjustments and personalized instructions should be discussed with your doctor.
Data suggests that Gefifect 250mg Tablet 10s is likely safe to use in liver disease and does not require dose adjustment. However, it's best to consult your doctor when prescribed.
Gefifect 250mg Tablet 10s functions by restraining certain communication channels in cancer cells. It aims at an entity known as epidermal growth factor receptor (EGFR), present on both standard and cancer cells. By halting the initiation of particular proteins associated with this receptor, Gefitinib hampers the communication avenues that cancer cells depend on for expansion and survival. On a basic level, it's similar to deactivating the trigger that causes cancer cells to proliferate unmanageably, aiding in reducing or halting their growth.
Non-small cell lung cancer (NSCLC) is the most common type of lung cancer. It occurs when abnormal cells grow and multiply in the lung tissues. NSCLC can be divided into three main types: adenocarcinoma, squamous cell carcinoma, and large cell carcinoma. NSCLC can cause symptoms such as coughing, chest pain, shortness of breath, and weight loss.
Content Updated on
Saturday, 17 Feburary, 2024Prescription Required
Simplify your healthcare journey with Indian Government's ABHA card. Get your card today!
Create ABHA